secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001683168-24-001635
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants Sonoma Pharmaceuticals 180-day extension to meet $1.00 bid price rule
--------------------------------------------------------------------------------

- Company received until September 16, 2024 to regain compliance with Nasdaq minimum $1.00 closing bid price rule.
- Initial compliance deadline of March 20, 2024 was not met; deficiency first disclosed in September 2023.
- If bid price closes at $1.00+ for 10 consecutive business days before Sept 16, Nasdaq will confirm compliance.
- Failure to cure by Sept 16 could lead to delisting; company may appeal or consider reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824001635/0001683168-24-001635-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824001635/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001635

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer